Results 91 to 100 of about 8,341,201 (317)

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

open access: yesMolecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla   +9 more
wiley   +1 more source

The Relationship Between Patient Safety Culture and Medical Error Tendency in Surgical Nurses and Affecting Factors

open access: yesSağlık ve Hemşirelik Yönetimi Dergisi
Aim: The objective of this study was to evaluate the impact of patient safety culture on the tendency of surgical nurses to make medical errors. Method: This study employed a descriptive cross-sectional design.
Gülbanu Zencir   +3 more
doaj   +1 more source

Errors in Clinician–Parent Communication during Neonatal Hospitalization

open access: yesChildren, 2019
Error in clinician−parent communication is not a new issue in pediatrics. It has been the impetus behind national initiatives, namely, family-centered rounds.
John M. Idso, Mir A. Basir
doaj   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

open access: yesMolecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan   +16 more
wiley   +1 more source

Errores médicos Medical Errors

open access: yesActa Médica Costarricense, 2009
El error médico es cualquier falla ocurrida durante la atención de salud que haya causado algún tipo de daño al paciente, y cuyo origen puede relacionarse con la organización e implementación del servicio, a través de múltiples y complejos mecanismos ...
Ana Teresa Alvarado-Guevara   +1 more
doaj  

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Does the perception of severity of medical error differ between varying levels of clinical seniority?

open access: yes, 2018
Iqbal Khan,1 Meret Arsanious2 1Northampton General Hospital NHS Trust, Northampton, UK; 2Epsom and St Helier University Hospitals NHS Trust, London, UK Background and purpose: The Francis Report called for a more “open culture” to empower ...
Khan I, Arsanious M
core  

Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining

open access: yesMolecular Oncology, EarlyView.
IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis   +3 more
wiley   +1 more source

Flow Enabled Target Capture Halbach‐based magnetic enrichment increases circulating tumor cell capture from blood in metastatic cancer patients

open access: yesMolecular Oncology, EarlyView.
Pair‐wise comparison of the CellSearch and FETCH enrichment technologies for circulating tumor cells (CTCs) from metastatic breast, prostate, and small cell lung cancer patients shows an increased capture of CTCs using FETCH enrichment. The clinical implementation of circulating tumor cells (CTCs) as a predictive tool for therapy efficacy in the ...
Michiel Stevens   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy